ALLO
Price
$2.04
Change
+$0.08 (+4.08%)
Updated
Jun 18, 11:23 AM (EDT)
Capitalization
676.5M
48 days until earnings call
Intraday BUY SELL Signals
NBTX
Price
$35.95
Change
-$0.12 (-0.33%)
Updated
Jun 18, 10:37 AM (EDT)
Capitalization
1.78B
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALLO vs NBTX

ALLO vs NBTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALLO vs. NBTX commentary
Jun 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and NBTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 18, 2026
Stock price -- (ALLO: $1.96 vs. NBTX: $35.90)
Brand notoriety: ALLO and NBTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 55% vs. NBTX: 93%
Market capitalization -- ALLO: $676.5M vs. NBTX: $1.78B
ALLO [@Biotechnology] is valued at $676.5M. NBTX’s [@Biotechnology] market capitalization is $1.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $116.49B to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileNBTX’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • NBTX’s FA Score: 0 green, 5 red.
According to our system of comparison, NBTX is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 5 TA indicator(s) are bullish while NBTX’s TA Score has 2 bullish TA indicator(s).

  • ALLO’s TA Score: 5 bullish, 3 bearish.
  • NBTX’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than NBTX.

Price Growth

ALLO (@Biotechnology) experienced а +10.11% price change this week, while NBTX (@Biotechnology) price change was +7.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.34%. For the same industry, the average monthly price growth was +8.33%, and the average quarterly price growth was +2104.08%.

Reported Earning Dates

ALLO is expected to report earnings on Aug 05, 2026.

NBTX is expected to report earnings on Sep 30, 2026.

Industries' Descriptions

@Biotechnology (+2.34% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBTX($1.78B) has a higher market cap than ALLO($677M). NBTX YTD gains are higher at: 55.277 vs. ALLO (43.066).
ALLONBTXALLO / NBTX
Capitalization677M1.78B38%
EBITDA-160.41MN/A-
Gain YTD43.06655.27778%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash267MN/A-
Total Debt72.6MN/A-
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLONBTX
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 1 day ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ALLO
Daily Signal:
Gain/Loss:
NBTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAIEX18.25N/A
N/A
Optimum International A
TSVRX21.90N/A
N/A
PGIM Quant Solutions Small-Cap Val R
VSGAX123.86N/A
N/A
Vanguard Small Cap Growth Index Admiral
JPVRX22.56N/A
N/A
JPMorgan Developed International ValueR5
TRSLX6.44N/A
N/A
Transamerica Small Cap Value R